Update on Normal Tension Glaucoma

Overview

Journal J Ophthalmic Vis Res

Specialty Ophthalmology

Date 2016 Jul 15

PMID 27413503

Citations 59

Authors

Jyotiranjan Mallick

Lily Devi

Pradeep K Malik

Jogamaya Mallick

Affiliations

Soon will be listed here.

Abstract

Normal tension glaucoma (NTG) is labelled when typical glaucomatous disc changes, visual field defects and open anterior chamber angles are associated with intraocular pressure (IOP) constantly below 21 mmHg. Chronic low vascular perfusion, Raynaud's phenomenon, migraine, nocturnal systemic hypotension and over-treated systemic hypertension are the main causes of normal tension glaucoma. Goldmann applanation tonometry, gonioscopy, slit lamp biomicroscopy, optical coherence tomography and visual field analysis are the main tools of investigation for the diagnosis of NTG. Management follows the same principles of treatment for other chronic glaucomas: To reduce IOP by a substantial amount, sufficient to prevent disabling visual loss. Treatment is generally aimed to lower IOP by 30% from pre-existing levels to 12-14 mmHg. Betaxolol, brimonidine, prostaglandin analogues, trabeculectomy (in refractory cases), systemic calcium channel blockers (such as nifedipine) and 24-hour monitoring of blood pressure are considered in the management of NTG. The present review summarises risk factors, causes, pathogenesis, diagnosis and management of NTG.

Citing Articles

C/EBP Homologous Protein Expression in Retinal Ganglion Cells Induces Neurodegeneration in Mice.

Mayhew W, Kaipa B, Li L, Maddineni P, Sundaresan Y, Clark A Int J Mol Sci. 2025; 26(5).

PMID: 40076484 PMC: 11899906. DOI: 10.3390/ijms26051858.

Efficacy of Ginkgo biloba on parameters in glaucoma: A systematic review.

Prinz J, Prokosch V, Wang X, Feng Y, Walter P, Fuest M PLoS One. 2025; 20(2):e0314644.

PMID: 39951447 PMC: 11828365. DOI: 10.1371/journal.pone.0314644.

Intraocular pressure and optical coherence tomography concerning visual field outcomes in "green" patients: An observational study.

Chou J, Tseng P, Hu H, Yen C Medicine (Baltimore). 2024; 103(46):e40518.

PMID: 39560596 PMC: 11575967. DOI: 10.1097/MD.0000000000040518.

Genome-wide meta-analysis identifies 22 loci for normal tension glaucoma with significant overlap with high tension glaucoma.

Diaz-Torres S, He W, Yu R, Khawaja A, Hammond C, Hysi P Nat Commun. 2024; 15(1):9959.

PMID: 39551815 PMC: 11570636. DOI: 10.1038/s41467-024-54301-2.

Discriminating Diseases Mimicking Normal-Tension Glaucoma (NTG) from NTG.

Ryu H, Kim S, Shin H, Park C, Park H J Clin Med. 2024; 13(21).

PMID: 39518723 PMC: 11546223. DOI: 10.3390/jcm13216585.

References

Gliklich R, Steinmann W, Spaeth G . Visual field change in low-tension glaucoma over a five-year follow-up. Ophthalmology. 1989; 96(3):316-20. DOI: 10.1016/s0161-6420(89)33070-3. View

Drance S . Some factors in the production of low tension glaucoma. Br J Ophthalmol. 1972; 56(3):229-42. PMC: 1208757. DOI: 10.1136/bjo.56.3.229. View

Ritch R, Darbro B, Menon G, Khanna C, Solivan-Timpe F, Roos B . TBK1 gene duplication and normal-tension glaucoma. JAMA Ophthalmol. 2014; 132(5):544-8. PMC: 4372533. DOI: 10.1001/jamaophthalmol.2014.104. View

. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998; 126(4):487-97. DOI: 10.1016/s0002-9394(98)00223-2. View

Park H, Park S, Park C . Central visual field progression in normal-tension glaucoma patients with autonomic dysfunction. Invest Ophthalmol Vis Sci. 2014; 55(4):2557-63. DOI: 10.1167/iovs.13-13742. View

. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998; 126(4):498-505. DOI: 10.1016/s0002-9394(98)00272-4. View

Mojon D, Hess C, Goldblum D, Fleischhauer J, Koerner F, Bassetti C . High prevalence of glaucoma in patients with sleep apnea syndrome. Ophthalmology. 1999; 106(5):1009-12. DOI: 10.1016/S0161-6420(99)00525-4. View

Shields M . Normal-tension glaucoma: is it different from primary open-angle glaucoma?. Curr Opin Ophthalmol. 2008; 19(2):85-8. DOI: 10.1097/ICU.0b013e3282f3919b. View

Phelps C, Corbett J . Migraine and low-tension glaucoma. A case-control study. Invest Ophthalmol Vis Sci. 1985; 26(8):1105-8. View

10.

Bloomfield S . The results of surgery for low-tension glaucoma. Am J Ophthalmol. 1953; 36(8):1067-70. DOI: 10.1016/0002-9394(53)91887-x. View

11.

Shetgar A, Mulimani M . The central corneal thickness in normal tension glaucoma, primary open angle glaucoma and ocular hypertension. J Clin Diagn Res. 2013; 7(6):1063-7. PMC: 3708199. DOI: 10.7860/JCDR/2013/4292.3022. View

12.

Berenson K, Kymes S, Walt J, Siegartel L . The relationship of mean deviation scores and resource utilization among patients with glaucoma: a retrospective United States and European chart review analysis. J Glaucoma. 2009; 18(5):390-4. DOI: 10.1097/IJG.0b013e3181879ea0. View

13.

Quigley H, Broman A . The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90(3):262-7. PMC: 1856963. DOI: 10.1136/bjo.2005.081224. View

14.

Heijl A, Leske M, Bengtsson B, Hyman L, Bengtsson B, Hussein M . Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002; 120(10):1268-79. DOI: 10.1001/archopht.120.10.1268. View

15.

Lee A, Rochtchina E, Wang J, Healey P, Mitchell P . Does smoking affect intraocular pressure? Findings from the Blue Mountains Eye Study. J Glaucoma. 2003; 12(3):209-12. DOI: 10.1097/00061198-200306000-00005. View

16.

Henry E, Newby D, Webb D, OBrien C . Peripheral endothelial dysfunction in normal pressure glaucoma. Invest Ophthalmol Vis Sci. 1999; 40(8):1710-4. View

17.

Anderson D . Glaucoma, capillaries and pericytes. 1. Blood flow regulation. Ophthalmologica. 1996; 210(5):257-62. DOI: 10.1159/000310722. View

18.

Sawada A, Kitazawa Y, Yamamoto T, Okabe I, Ichien K . Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma. Ophthalmology. 1996; 103(2):283-8. DOI: 10.1016/s0161-6420(96)30703-3. View

19.

Netland P, Chaturvedi N, Dreyer E . Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol. 1993; 115(5):608-13. DOI: 10.1016/s0002-9394(14)71458-8. View

20.

Gramer E, Althaus G, LEYDHECKER W . [Site and depth of glaucomatous visual field defects in relation to the size of the neuroretinal edge zone of the optic disk in glaucoma without hypertension, simple glaucoma, pigmentary glaucoma. A clinical study with the Octopus perimeter 201 and...]. Klin Monbl Augenheilkd. 1986; 189(3):190-8. DOI: 10.1055/s-2008-1050784. View